Immune Dysregulation in Human Immunodeficiency Virus Infection: Know It, Fix It, Prevent It?

Overview

Journal J Intern Med

Specialty General Medicine

Date 2008 Dec 20

PMID 19093962

Citations 56

Authors

A Boasso

G M Shearer

C Chougnet

Affiliations

Soon will be listed here.

Abstract

Infection of humans by the human immunodeficiency virus (HIV) causes a progressive, multifactorial impairment of the immune system eventually leading to the acquired immunodeficiency syndrome (AIDS). No cure or vaccine exists yet against HIV infection. More worrisome is the fact that despite having identified HIV as the cause of the AIDS, we still do not understand what pathogenic mechanisms lead to the debacle of the immune system. In this review we consider the extent and the limits of our knowledge of HIV pathogenesis, and how this knowledge may be used to design preventive and therapeutic approaches.

Citing Articles

Identification of Pathogens in HIV-Infected Patients Using Metagenomic Next-Generation Sequencing (mNGS) as Compared to Conventional Microbiological Tests (CMTs).

Zhu X, Cao L, Wang J, Lu X, Huang Z, Wen X Infect Drug Resist. 2025; 18:929-940.

PMID: 39990777 PMC: 11844195. DOI: 10.2147/IDR.S491946.

Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024.

Schemelev A, Davydenko V, Ostankova Y, Reingardt D, Serikova E, Zueva E Viruses. 2024; 16(11).

PMID: 39599797 PMC: 11599013. DOI: 10.3390/v16111682.

Evaluation of the mindray CL900i CLIA HIV Ag/Ab combo assay for sensitive and specific HIV screening compared to established methods.

Nasrallah G, Younes N, Khalid H, Al-Emadi J, Younes S, Abouassali M Sci Rep. 2024; 14(1):28177.

PMID: 39548153 PMC: 11568275. DOI: 10.1038/s41598-024-78271-z.

Oral Manifestations of HIV Infection and Dental Health Needs of Children with HIV Attending HIV Treatment Clinics in Western Cameroon.

Agbor A, Sohal K, Nguimfack N, Tarkang E, George E, Naidoo S Int J MCH AIDS. 2024; 13:e022.

PMID: 39526170 PMC: 11544498. DOI: 10.25259/IJMA_7_2024.

HIV vaccination: Navigating the path to a transformative breakthrough-A review of current evidence.

Scott G, Worku D Health Sci Rep. 2024; 7(9):e70089.

PMID: 39319247 PMC: 11420300. DOI: 10.1002/hsr2.70089.

References

Andersson J, Kinloch S, Sonnerborg A, Nilsson J, Fehniger T, Spetz A . Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J Infect Dis. 2002; 185(9):1355-8. DOI: 10.1086/340124. View

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

Raffatellu M, Santos R, Verhoeven D, George M, Wilson R, Winter S . Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008; 14(4):421-8. PMC: 2901863. DOI: 10.1038/nm1743. View

Siliciano R . The role of CD4 in HIV envelope-mediated pathogenesis. Curr Top Microbiol Immunol. 1996; 205:159-79. DOI: 10.1007/978-3-642-79798-9_8. View

Thoulouze M, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A . Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity. 2006; 24(5):547-61. DOI: 10.1016/j.immuni.2006.02.016. View

Lee C, Liu Q, Tomkowicz B, Yi Y, Freedman B, Collman R . Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. J Leukoc Biol. 2003; 74(5):676-82. DOI: 10.1189/jlb.0503206. View

Boasso A, Hardy A, Landay A, Martinson J, Anderson S, Dolan M . PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol. 2008; 129(1):132-44. PMC: 2771672. DOI: 10.1016/j.clim.2008.05.009. View

Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S . Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J Infect Dis. 2006; 193(11):1557-66. DOI: 10.1086/503874. View

Leligdowicz A, Yindom L, Onyango C, Sarge-Njie R, Alabi A, Cotten M . Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest. 2007; 117(10):3067-74. PMC: 1964515. DOI: 10.1172/JCI32380. View

10.

Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E . Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol. 2004; 78(7):3233-43. PMC: 371059. DOI: 10.1128/jvi.78.7.3233-3243.2004. View

11.

Banda N, Bernier J, Kurahara D, Kurrle R, Haigwood N, Sekaly R . Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med. 1992; 176(4):1099-106. PMC: 2119378. DOI: 10.1084/jem.176.4.1099. View

12.

Wedemeyer H, He X, Nascimbeni M, Davis A, Greenberg H, Hoofnagle J . Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002; 169(6):3447-58. DOI: 10.4049/jimmunol.169.6.3447. View

13.

Eggena M, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C . Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol. 2005; 174(7):4407-14. DOI: 10.4049/jimmunol.174.7.4407. View

14.

Rosenberg E, Altfeld M, Poon S, Phillips M, Wilkes B, Eldridge R . Immune control of HIV-1 after early treatment of acute infection. Nature. 2000; 407(6803):523-6. DOI: 10.1038/35035103. View

15.

Bonaparte M, Barker E . Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS. 2003; 17(4):487-94. DOI: 10.1097/00002030-200303070-00003. View

16.

Moir S, Malaspina A, Pickeral O, Donoghue E, Vasquez J, Miller N . Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med. 2004; 200(7):587-99. View

17.

Dyer W, Geczy A, Kent S, McIntyre L, Blasdall S, Learmont J . Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS. 1997; 11(13):1565-74. DOI: 10.1097/00002030-199713000-00004. View

18.

Toulza F, Heaps A, Tanaka Y, Taylor G, Bangham C . High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2007; 111(10):5047-53. PMC: 2602587. DOI: 10.1182/blood-2007-10-118539. View

19.

Herbeuval J, Shearer G . Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?. AIDS Rev. 2006; 8(1):3-8. View

20.

Sakai K, Dimas J, Lenardo M . The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest. Proc Natl Acad Sci U S A. 2006; 103(9):3369-74. PMC: 1413893. DOI: 10.1073/pnas.0509417103. View